Trial
NCT02379650
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
Phase IIWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
University of Utah
Collaborators
Intermountain Health Care, Inc.
Condition
Recurrent Pregnancy Loss
Intervention
Hydroxychloroquine (HCQ)
Why stopped
Testing required by FDA for IND approval was too expensive to move forward with conduct of the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-12